Skip to content

Integrating Palliative Care Into Self-Management of Breast Cancer

Integrating Palliative Care Into Self-Management of Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02148575
Enrollment
109
Registered
2014-05-28
Start date
2014-06-30
Completion date
2017-01-31
Last updated
2017-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Palliative Care, Self-management, Breast Cancer

Brief summary

The purpose of this study is to test a psycho-educational intervention, Managing Cancer Care: A Personal Guide (MCC), that is intended to improve patients' knowledge of palliative care and to facilitate its timely integration into self-management of their breast cancer. The MCC will be tested with patients with Stage I-IV breast cancer at baseline, one, and three months following enrollment. The intervention group will receive the MCC, and the attention-control group will receive a symptom management toolkit. Participants' family caregivers will also be enrolled to provide information on patients' self-management. Investigators hypothesize that users of MCC, as compared to attention-control participants, will demonstrate improved knowledge, feelings, and behaviors related to self-management of their cancer care. This innovative research can help to establish palliative care as a mainstay of self-management interventions that target serious illnesses.

Interventions

BEHAVIORALSymptom Management Group

Sponsors

Yale University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over the age of 21 * Stage I-IV breast cancer * Live in the State of Connecticut * Speak English * Receiving any kind of treatment for breast cancer * Prognosis of at least 6 months

Design outcomes

Primary

MeasureTime frame
Knowledge of Care Options Test1 month

Secondary

MeasureTime frame
Medical Communication Competence Scale1 month
Measurement of Transitions Scale1 month
Chronic Disease Self-Efficacy Scale1 month
Control Preferences Scale1 month
Uncertainty in Illness Scale1 month
Health Care Utilization Form3 months
Goals of Care Conversations Form1 month
Hospital Anxiety and Depression Scale1 month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026